December 22, 2016
Teva Pharmaceutical Industries Limited
Foreign Corrupt Practices Act
SANCTION AMOUNT: $236,101,824
Defendants: Teva Pharmaceutical Industries Limited
Part of a larger settlement of more than $519 million to settle parallel civil and criminal charges of FCPA violations due to paying bribes to government officials in Russia, Ukraine and Mexico. The company allegedly made more than $214 million in illicit profits by virtue of the bribes, which led to increased market share, favorable regulatory and formulary approvals, and favorable drug purchase and prescription decisions.
- Key Docs
- Official SEC press release